Small Business: Applied Immunology and Vaccine Development – DCAI (10)
This special emphasis panel reviews small business applications in the general area of immunological therapies and covers all aspects of the development of vaccines against infectious diseases.
Review Dates
Topics
- Immunotherapeutic regimens for autoimmune and immune-mediated diseases, including allergy, diabetes, multiple sclerosis, rheumatoid arthritis, and systemic lupus erythematosus
- Vaccine design, formulation, and production for all classes of vaccines targeting infectious diseases
- Pre-clinical and clinical vaccine testing, including protection from disease, immune response characterizations, toxicology, and safety studies
Shared Interests and Overlaps:
There are shared interests with Diabetes, Metabolism, Nutrition and Obesity [EMS (10)] for small business applications examining type 1 diabetes onset and progression. Applications addressing the endocrine, metabolic and nutritional basis of diabetes and obesity may be reviewed in EMS (10). Applications focusing on the immune system may be reviewed here.
There are shared interests with Skeletal Muscle, Oral and Skin Sciences [MSOS (10)] for small business applications on immune-mediated diseases. Applications that focus on the use of existing therapies that affect the skin, muscle, bone, and joints may be reviewed in MSOS (10). Applications that focus on therapy development are reviewed here.
There are shared interests with Respiratory Sciences [RCCS (11)] for small business applications addressing the development of therapeutics that are focused on the pulmonary system and related organs. Applications addressing diagnostics, medical devices and therapeutics that are focused on the entire pulmonary system and related organs may be reviewed in RCCS (11), while those examining immunotherapeutic regimens for asthma and allergic diseases may be reviewed here.
There are shared interests with small business panels in the Cancer Diagnosis, Prevention & Therapeutics (CDPT) Review Branch. Small business applications addressing experimental therapy for neoplastic diseases in in vitro and in vivo model systems may be reviewed in the CDPT Branch, while applications examining immune cell imbalances or tolerance in transplant models may be reviewed here.
